• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Nicholas Shukeir, Ani Arakelian, Salam Kadhim, Seema V Garde, Shafaat Ahmed Rabbani
  • Medicine
  • Cancer research
  • 2003 (First Published: 1 May 2003)
  • Prostate cancer is a common malignancy affecting men, which is often associated with skeletal metastases resulting in significant morbidity and mortality. In this hormone-dependent cancer, low levelsContinue Reading
  • Borhane Annabi, Mounia Bouzeghrane, +10 authors Richard. Auteur du texte Béliveau
  • Biology, Medicine
  • Clinical & Experimental Metastasis
  • 2005 (First Published: 1 September 2005)
  • Purpose: PCK3145 is a synthetic peptide corresponding to amino acids 31–45 of prostate secretory protein 94, which can reduce experimental skeletal metastases and prostate tumor growth in vivo. PartContinue Reading
  • Seema V Garde, Vathsala S. Basrur, +8 authors Dean G. Tang
  • Biology, Medicine
  • The Prostate
  • 1999 (First Published: 1 February 1999)
  • BACKGROUND PSP94 (prostate secretory protein of 94 aa; also called PIP), one of the predominant proteins secreted into the seminal fluid, was proposed as an independent diagnostic/prognostic markerContinue Reading
  • Borhane Annabi, Mounia Bouzeghrane, +7 authors Richard. Auteur du texte Béliveau
  • Biology, Medicine
  • Anti-cancer drugs
  • 2006 (First Published: 1 April 2006)
  • PCK3145 is a synthetic peptide corresponding to amino acids 31-45 of prostate secretory protein 94 which can reduce experimental skeletal metastases and prostate tumor growth. These anti-metastaticContinue Reading
  • S. Lamy, M. L. Torres Ruiz, +5 authors Borhane Annabi
  • Biology, Medicine
  • International journal of cancer
  • 2006 (First Published: 1 May 2006)
  • We have previously observed that the synthetic peptide corresponding to amino acids 31-45 (PCK3145) of PSP94 can reduce prostate tumor growth in vivo. Moreover, a recently concluded phase IIaContinue Reading